We also considered IL-6, a marker whose production is rather reduced in COPD and cystic fibrosis in response to PAMPs (Knobloch et al. 2011b; Armstrong et al. 2009; John et al. 2010). The gene discussed is IL6; the disease is chronic obstructive pulmonary disease.